X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
RELIGARE ENT. Announces Quarterly Results (3QFY19); Net Profit Up 75.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RELIGARE ENT. Announces Quarterly Results (3QFY19); Net Profit Up 75.2%
Fri, 22 Feb

RELIGARE ENT. has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

RELIGARE ENT. Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m78138-40.4%-90.1%
Other incomeRs m110111512.8%8575.0%
TurnoverRs m801151226.8%53.5%
ExpensesRs m3641071081.2%-70.3%
Gross profitRs m-286-94-100
DepreciationRs m522-10.9%-60.7%
InterestRs m127134116-13.7%-9.3%
Profit before taxRs m-417-128-103
TaxRs m0000.0%0.0%
Profit after taxRs m-417-128-103
Gross profit margin%-364.5-716.2-1,285.9
Effective tax rate%0.00.00.0
Net profit margin%-523.1-112.1-84.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 90.1% on a year-on-year (YoY) basis. The expenses were down by 70.3% YoY during the same period.
  • The company's operating profit declined by 64.9% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 1285.9% in 3QFY19 as against 364.5% in 3QFY18.
  • Depreciation charges declined by 60.7% and finance costs declined by 9.3% YoY, respectively.
  • Other income increased by 8575.0% YoY during the quarter.
  • Net profit for the quarter increased by 75.2% YoY. Net profit margins during the quarter increased from -523.1% in 3QFY18 to -84.4% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 40.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 1.2% QoQ during the same period.
  • The company's operating profit declined by 7.0% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 1285.9% in 3QFY19 as against 716.2% in 2QFY18.
  • Net profit for the quarter increased by 19.6% QoQ, while net profit margins increased from -111.3% in 2QFY18 to -84.4% in 3QFY19.

To see how RELIGARE ENT. has performed over the last eight quarters, please visit here.

RELIGARE ENT. Share Price Performance

Over the last one year, RELIGARE ENT. share price has moved up from Rs 54.4 to Rs 19.6, registering a Loss of Rs 34.8 or around 63.9%.

Overall, the S&P BSE SENSEX is up 6.0% over the year.

Current Valuations

At the current price of Rs 19.6, the price to book value (P/BV) ratio of RELIGARE ENT. stands at 0.2 times.

Equitymaster requests your view! Post a comment on "RELIGARE ENT. Announces Quarterly Results (3QFY19); Net Profit Up 75.2%". Click here!

  

Related Views on News

RELIGARE ENT. 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of RELIGARE ENT. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of RELIGARE ENT.. Also includes updates on the valuation of RELIGARE ENT..

RELIGARE ENT. Announces Quarterly Results (2QFY19); Net Profit Up 57.9% (Quarterly Result Update)

Nov 29, 2018 | Updated on Nov 29, 2018

For the quarter ended September 2018, RELIGARE ENT. has posted a net profit of Rs 128 m (up 57.9% YoY). Sales on the other hand came in at Rs 13 m (down 50.7% YoY). Read on for a complete analysis of RELIGARE ENT.'s quarterly results.

RELIGARE ENT. Announces Quarterly Results (4QFY18); Net Profit Up 27.2% (Quarterly Result Update)

Jun 4, 2018 | Updated on Jun 4, 2018

For the quarter ended March 2018, RELIGARE ENT. has posted a net profit of Rs 643 m (up 27.2% YoY). Sales on the other hand came in at Rs 3 m (down 81.0% YoY). Read on for a complete analysis of RELIGARE ENT.'s quarterly results.

CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)

Aug 7, 2018

Should you apply to the IPO of CreditAccess Grameen Ltd?

HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)

Jul 20, 2018

Should you subscribe to the IPO of HDFC AMC Ltd?

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

A 90% Chance of Auto Stocks Moving Up This April(Profit Hunter)

Apr 5, 2019

The Auto index ended on a positive note in the month of April in 9 out of last 10 years. This Auto stock is best placed to benefit from the upswing in this sector.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

RELIGARE ENT. SHARE PRICE


Apr 18, 2019 03:37 PM

TRACK RELIGARE ENT.

  • Track your investment in RELIGARE ENT. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

RELIGARE ENT. 5-YR ANALYSIS

COMPARE RELIGARE ENT. WITH

MARKET STATS